Edwards Lifesciences (EW)

Edwards Lifesciences (EW) Stock Price & Analysis


EW Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$60.57 - $94.87
Previous Close$68.26
Average Volume (3M)4.37M
Market Cap
Enterprise Value$41.04B
Total Cash (Recent Filing)$1.86B
Total Debt (Recent Filing)$691.10M
Price to Earnings (P/E)29.2
Feb 01, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.34
Shares Outstanding606,500,000
10 Day Avg. Volume4,457,198
30 Day Avg. Volume4,372,597
Standard Deviation0.09
Financial Highlights & Ratios
Price to Book (P/B)8.55
Price to Sales (P/S)7.69
Price to Cash Flow (P/CF)25.60
P/FCF Ratio28.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.05
Enterprise Value/Gross Profit9.54
Enterprise Value/Ebitda32.04
Price Target Upside12.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering20



Ownership Overview

23.53% Mutual Funds
39.21% Other Institutional Investors
36.37% Public Companies and Individual Investors


What was Edwards Lifesciences’s price range in the past 12 months?
Edwards Lifesciences lowest stock price was $60.57 and its highest was $94.87 in the past 12 months.
    What is Edwards Lifesciences’s market cap?
    Currently, no data Available
    When is Edwards Lifesciences’s upcoming earnings report date?
    Edwards Lifesciences’s upcoming earnings report date is Feb 01, 2024 which is in 54 days.
      How were Edwards Lifesciences’s earnings last quarter?
      Edwards Lifesciences released its earnings results on Oct 25, 2023. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.593 by -$0.003.
        Is Edwards Lifesciences overvalued?
        According to Wall Street analysts Edwards Lifesciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Edwards Lifesciences pay dividends?
          Edwards Lifesciences does not currently pay dividends.
          What is Edwards Lifesciences’s EPS estimate?
          Edwards Lifesciences’s EPS estimate is $0.64.
            How many shares outstanding does Edwards Lifesciences have?
            Edwards Lifesciences has 606,500,000 shares outstanding.
              What happened to Edwards Lifesciences’s price movement after its last earnings report?
              Edwards Lifesciences reported an EPS of $0.59 in its last earnings report, missing expectations of $0.593. Following the earnings report the stock price went down -8.136%.
                Which hedge fund is a major shareholder of Edwards Lifesciences?
                Among the largest hedge funds holding Edwards Lifesciences’s share is Fisher Asset Management LLC. It holds Edwards Lifesciences’s shares valued at 507M.


                  Company Description

                  Edwards Lifesciences

                  Incorporated in 1958, California-based Edwards Lifesciences Corp. is a medical technology company, which specializes in structural heart disease and critical care and surgical monitoring. It reports in three segments: Transcatheter Aortic Valve Replacements, Transcatheter Mitral and Tricuspid Therapies and Surgical Structural Heart and Critical Care.


                  Top 5 ETFs holding EW

                  Market Value
                  Smart Score
                  Global X S&P 500 Covered Call ETF
                  iShares ESG Screened S&P 500 ETF
                  Global X S&P 500 Covered Call & Growth ETF
                  Global X S&P 500 ESG Covered Call ETF
                  Global X S&P 500 Tail Risk ETF
                  Up to five ETFs with an Outperform Smart Score that hold EW. The ETFs are listed according to market value of EW within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Abbott Labs
                  Boston Scientific
                  Becton Dickinson

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis